Literature DB >> 25027070

Impaired hypoxia-inducible factor (HIF) regulation by hyperglycemia.

Sergiu-Bogdan Catrina1.   

Abstract

The mechanisms that contribute to the development of diabetes complications remain unclear. A defective reaction of tissues to hypoxia has recently emerged as a new pathogenic mechanism and consists of a complex repression of hypoxia-inducible factor (HIF), which is the main regulator of the adaptive response to hypoxia. This paper discusses the mechanisms by which hyperglycaemia contributes to HIF repression in diabetes. Furthermore, a comprehensive analysis of the functional relevance of these new findings to the development of chronic diabetes complications is provided, along with examples from animal models and clinics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027070     DOI: 10.1007/s00109-014-1166-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  99 in total

1.  Effect of pioglitazone on diabetic nephropathy and expression of HIF-1α and VEGF in the renal tissues of type 2 diabetic rats.

Authors:  Xiangjin Xu; Pin Chen; Quanlin Zheng; Yanqiao Wang; Wenyu Chen
Journal:  Diabetes Res Clin Pract       Date:  2011-04-22       Impact factor: 5.602

Review 2.  The pathogenesis of early retinal changes of diabetic retinopathy.

Authors:  G B Arden; S Sivaprasad
Journal:  Doc Ophthalmol       Date:  2012-02       Impact factor: 2.379

3.  Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

Authors:  Vassiliki Poulaki; Wenying Qin; Antonia M Joussen; Peter Hurlbut; Stanley J Wiegand; John Rudge; George D Yancopoulos; Anthony P Adamis
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 4.  Oxygen homeostasis.

Authors:  Gregg L Semenza
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 May-Jun

5.  Regulation of vascular endothelial growth factor expression by advanced glycation end products.

Authors:  C Treins; S Giorgetti-Peraldi; J Murdaca; E Van Obberghen
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

6.  Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function.

Authors:  Sergiu-Bogdan Catrina; Kensaku Okamoto; Teresa Pereira; Kerstin Brismar; Lorenz Poellinger
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

7.  Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes.

Authors:  K H Gabbay; L O Merola; R A Field
Journal:  Science       Date:  1966-01-14       Impact factor: 47.728

8.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

9.  Impact of the hypoxia-inducible factor-1 α (HIF1A) Pro582Ser polymorphism on diabetes nephropathy.

Authors:  Harvest F Gu; Xiaowei Zheng; Norhashimah Abu Seman; Tianwei Gu; Ileana Ruxandra Botusan; Vivekananda Gupta Sunkari; Ezarul Faradianna Lokman; Kerstin Brismar; Sergiu-Bogdan Catrina
Journal:  Diabetes Care       Date:  2012-09-18       Impact factor: 19.112

10.  Glucotoxicity induces glucose-6-phosphatase catalytic unit expression by acting on the interaction of HIF-1α with CREB-binding protein.

Authors:  Amandine Gautier-Stein; Maud Soty; Julien Chilloux; Carine Zitoun; Fabienne Rajas; Gilles Mithieux
Journal:  Diabetes       Date:  2012-07-10       Impact factor: 9.461

View more
  13 in total

Review 1.  Vitamin C: the known and the unknown and Goldilocks.

Authors:  S J Padayatty; M Levine
Journal:  Oral Dis       Date:  2016-04-14       Impact factor: 3.511

2.  Hypoxia negates hyperglycaemia-induced chemo-resistance in breast cancer cells: the role of insulin-like growth factor binding protein 2.

Authors:  Athba Al Qahtani; Jeff Holly; Claire Perks
Journal:  Oncotarget       Date:  2017-08-16

Review 3.  Hypoxia Inducible Factor as a Central Regulator of Metabolism - Implications for the Development of Obesity.

Authors:  Joana M Gaspar; Lício A Velloso
Journal:  Front Neurosci       Date:  2018-11-01       Impact factor: 4.677

4.  Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy.

Authors:  Neda Rajamand Ekberg; Sofie Eliasson; Young Wen Li; Xiaowei Zheng; Katerina Chatzidionysiou; Henrik Falhammar; Harvest F Gu; Sergiu-Bogdan Catrina
Journal:  J Diabetes Res       Date:  2019-05-12       Impact factor: 4.011

5.  Comprehensive metabolomic study of the response of HK-2 cells to hyperglycemic hypoxic diabetic-like milieu.

Authors:  Alberto Valdés; Francisco J Lucio-Cazaña; María Castro-Puyana; Coral García-Pastor; Oliver Fiehn; María Luisa Marina
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

6.  Repressed hypoxia inducible factor-1 in diabetes aggravates pulmonary aspergillus fumigatus infection through modulation of inflammatory responses.

Authors:  Yao Ye; Yu Chen; Jianjun Sun; Hanyin Zhang; Wenyang Li; Wei Wang; Xiaowei Zheng; Sergiu-Bogdan Catrina
Journal:  Clin Transl Med       Date:  2021-01

7.  HypoxamiR-210 accelerates wound healing in diabetic mice by improving cellular metabolism.

Authors:  Sampath Narayanan; Sofie Eliasson Angelstig; Cheng Xu; Jacob Grünler; Allan Zhao; Wan Zhu; Ning Xu Landén; Mona Ståhle; Jingping Zhang; Mircea Ivan; Raluca Georgiana Maltesen; Ileana Ruxandra Botusan; Neda Rajamand Ekberg; Xiaowei Zheng; Sergiu-Bogdan Catrina
Journal:  Commun Biol       Date:  2020-12-14

8.  HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients.

Authors:  Soumitra Mohanty; Witchuda Kamolvit; Silvia Zambrana; Eduardo Gonzales; Jonas Tovi; Kerstin Brismar; Claes-Göran Östenson; Annelie Brauner
Journal:  J Mol Med (Berl)       Date:  2021-10-15       Impact factor: 4.599

9.  Network Pharmacology Analysis of Traditional Chinese Medicine Formula Xiao Ke Yin Shui Treating Type 2 Diabetes Mellitus.

Authors:  Jiewen Zhou; Qiuyan Wang; Zhinan Xiang; Qilin Tong; Jun Pan; Luosheng Wan; Jiachun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-08       Impact factor: 2.629

10.  Tangeretin Ameliorates Glucose-Induced Podocyte Injury through Blocking Epithelial to Mesenchymal Transition Caused by Oxidative Stress and Hypoxia.

Authors:  Min-Kyung Kang; Soo-Il Kim; Su Yeon Oh; Woojin Na; Young-Hee Kang
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.